Properly coordinated metabolism and maintained metabolite homeostasis are important because altered metabolite homeostasis has a causal role in many human diseases, including cancer. Metabolite homeostasis is maintained by fine-tuned coordination of metabolite generation and utilization. Metabolite deregulation has recently been shown to alter the signaling pathways and reprogram epigenetic factors associated with tumorigenesis. Protein lysine acetylation is emerging as a metabolism-coordinating mechanism. Mechanistic studies have shown that acetylation may have roles in nutrient adaptation and in maintaining metabolite homeostasis by exerting regulatory effects on metabolic enzymes, metabolic pathways and metabolic networks. Here we review recent progress in the determination of the role of acetylation regulation in metabolism coordination. In particular, we review links between deregulated acetylation in metabolic enzymes and tumorigenesis. We further hypothesize on applications of the mediation of acetylation to restore deregulated metabolism coordination and thus develop novel means of cancer treatment.
BACKGROUND

Deregulated metabolism coordination and cancer
Aggressive carcinomas ferment glucose to lactate, a process typically restricted to anaerobic and low-oxygen conditions. This particular metabolic process was first described by Nobel laureate Otto Warburg and colleagues in the 1920s. 1, 2 It was named the Warburg effect in recognition of their contribution. Although the casual mechanism of Warburg effect remains to be elucidated, it is well accepted that cancer cells adopt metabolisms different from those of normal cells. Cancer cells have many of unique metabolic signatures. Although cancer cells have elevated rates of glucose uptake and glycolysis, and use large amounts of glutamine through a truncated tricarboxylic acid (TCA) cycle to sustain their growth, [3] [4] [5] [6] oxidative phosphorylation and glycolysis are disconnected in cancer cells. 3, 6 Alternations in metabolic coordination are thus key metabolic changes in tumor cells. This is evidenced by the observation that p53 mutations, the most common mutation found in cancer cells, causes systematic metabolic reprogramming, [7] [8] [9] and that activation of the hypoxiainducible factor pathway, another hallmark of cancer, also causes broad metabolic reprogramming in cancer cells. 10 Metabolite homeostasis has taken center stage in cancer research. Mounting evidences are suggesting that deregulation of certain metabolites, such as decreases in a-ketoglutarate, and accumulation of 2-hydroxylglutarate, TCA and glycolytic intermediary metabolites may all be causal factors of tumorigenesis. [11] [12] [13] A given metabolite's homeostasis is mainly determined by the balance between the rates of its synthesis and degradation pathways, and, under certain conditions, by the uptake and excretion of the metabolite. Mechanisms that maintain the balance of these metabolic pathways and the uptake and excretion may be useful to the prevention and treatment of cancer.
Acetylation disorder and cancer Allfrey et al.
14 and Pogo et al. 15 were the first to prove that acetylation takes place in histones. Acetylation at histones causes chromatin remodeling, and acetylation at transcription factors alters gene expression. [16] [17] [18] The importance of acetylation is strengthened by studies showing that deregulated acetylation is tightly linked to major diseases, such as cancer. For example, mutations in p300/CBP lysine acetyltransferases (KAT) are associated with acute myeloid leukemias. [19] [20] [21] [22] Acetylation has also been found to regulate the functions of important cancerassociated proteins, such as p53 and Ras. 17, 18, [23] [24] [25] [26] [27] [28] Deregulated acetylation is therefore associated with cancer.
In addition to its roles in transcriptional regulation and signaling modulation, acetylation has recently been shown to have significant roles in the regulation of metabolism and in helping to maintaining metabolites homeostasis, adding another venue to connect acetylation to cancer initiation and intervening. The current review discusses how acetylation coordinates metabolism and the likelihood that metabolic deregulation in cancer cells can be corrected by altering acetylation.
COORDINATION OF METABOLISM THROUGH ACETYLATION
Metabolism coordination
Organisms have fine-tuned metabolic mechanisms for orchestrating the conversion of diverse carbon substrates into cellular energy and building blocks. Metabolic network is composed of metabolic enzymes organized at different levels; metabolism is therefore regulated at these levels. The first level of regulation is that of individual metabolic enzymes. Gene transcription, allosteric regulation and posttranslational modifications regulate metabolism at this level. 29 Regulation can also take place at the level of the metabolic pathway. Several related metabolic enzymes catalyze a series of reactions to completely metabolize a specific metabolite. The activities of enzymes within a metabolic pathway have to be coordinated to synchronize every reaction within the pathway. At the third level, because the concentration of metabolites within a cell is determined by relative activities of different metabolic pathways that synthesize or utilize (degrade) it, metabolite homeostasis is determined by the coordinated activities of associated metabolic pathways. However, allosteric regulation, such as the potent inhibition of carnitine palmitoyltransferase I by TCA cycle intermediate malonylcoenzyme (CoA) to coordinate fatty-acid oxidation, is among the few reported means of coordination at the second and the third levels so far. However, their coordination is usually limited to few metabolic enzymes and can hardly qualify global coordinators.
Posttranslational modifications, such as phosphorylation and glycosylation, have been shown to have major roles in coordination on the second and third levels of metabolism ( Figure 1) . 30, 31 However, phosphorylation has only been found to regulate a few metabolic enzymes, such as the E1 component of pyruvate dehydrogenase complex, glycogen synthetase and glycogen phosphorylase (GP). [30] [31] [32] No universal means of metabolic coordination at the inter-pathway level is reported until the role of acetylation in metabolic control is elucidated.
Links between acetylation and metabolism The link between acetylation and metabolism became evident only after a published acetylation-peptide-based enrichment strategy. Using cultured HeLa cells and mouse livers, Kim et al. 33 identified 388 acetylation sites in 195 proteins. Their work expanded the number of known acetylation substrates from around 60 to nearly 200, showing 420% of acetylated proteins to be mitochondrial proteins, including many longevity regulators and metabolic enzymes. These findings link metabolic enzymes and cell metabolism directly to acetylation, supporting early isolated findings that acetyl-CoA synthetases from Salmonella and humans are regulated by acetylation. 34, 35 Our team used a modified approach to identify acetylated proteins in human liver tissues and identified 1047 acetylation protein substrates. 36 We found 44 metabolic enzymes in glycolysis, the TCA cycle, fatty-acid metabolism, the glycogen turnover pathway and the urea cycle to be acetylated, accounting for 91.7% (44/48) of the total number of enzymes in these pathways. The prevailingly acetylated metabolic enzymes were also found in an acetylome study in leukemia cells. Mann and colleagues found 41 of the enzymes in these pathways to be acetylated. Many of these enzymes were also found in our own work. 36, 37 However, Mann and colleagues did not indicate any relationship between acetylation and metabolism, despite extensive bioinformatic analysis.
In a parallel study, we performed an acetylome survey on prokaryotic cells and found almost every central pathway metabolic enzyme in Salmonella to be acetylated. 38 This was substantiated by another acetylome study, which showed the central pathways' metabolic enzymes to be heavily acetylated in Escherichia coli. 39 The prevalence of acetylation in bacterial and human metabolic enzymes indicated that acetylation could be a universally evolutionarily conserved metabolic regulatory mechanism. This notion was further supported by a series of studies. First, acetylated metabolic enzymes make up a high percentage of total metabolic enzyme. For example, a substantial amount (30-70%) of malate dehydrogenase 2 (MDH2) is acetylated in human cells. 36 This makes acetylation a likely regulatory mechanism of MDH2. Acetylation was found to regulate metabolic enzyme activity by activating, inactivating or destabilizing metabolic enzymes. 34, 36, [40] [41] [42] [43] It is worth noting that acetylation of different sites in the same protein may have distinct regulatory effects. We found that acetylation at lysines 185, 301, 307 and 314 activates MDH2, but Hebert et al. 36, 44 found that acetylation at lysine 239 may inactivate MDH2. Together, these findings confirmed the regulatory function of acetylation. Mitochondrial proteins include many metabolic enzymes, most of which are heavily acetylated. 33, 45, 46 The acetylation of mitochondrial proteins varies under different energy conditions. The acetylation of mitochondrial proteins can change during catabolite repression (CR) in a tissue-specific fashion. 45 These observations are consistent with the idea that acetylation is one of the key regulators of metabolism. 47, 48 Acetylation as a coordinator of metabolism To coordinate metabolic network, a general coordinator should be associated with all or most of the metabolic enzymes, and it should sense metabolic signals. Such general coordinator of metabolism is so far not identified. Acetylation has the potential to meet both criteria to be a general coordinator of metabolism. In addition to its prevalence in metabolic enzymes, as described above, reactions of acetylation and deacetylation both bear metabolic signals. All KATs use acetyl-CoA as an acetyl group donor. [49] [50] [51] Acetyl-CoA, which can be derived from any nutrient, causes the carbon atoms within the acetyl group to become oxidized through the TCA cycle for energy production. 52 The concentration of acetyl-CoA can indicate the abundance of nutrients (metabolites). On the other hand, nicotine adenine dinucleotide (NAD) þ -dependent sirtuins, also known as class III lysine deacetylases (KDACs), use NAD þ as co-substrate in their deacetylation reactions. Low levels of NAD þ persist when there are not enough nutrients or insufficient energy metabolic cofactors or energy factories (for example, mitochondria) to convert the nutrients into usable forms. 53 In this way, NAD þ can indicate cellular energy status. This statement holds true even in mitochondria, in which NAD þ levels remain at physiological levels following genotoxic stress; however, rodents' fasting increases levels of the NAD þ biosynthetic enzyme Nampt and causes a concomitant increase in mitochondrial NAD þ . 54 Although nonenzymatic acetylation is reported and there is no convincing proof of mitochondrial KATs identified so far, it is accepted that the acetylation status of a given metabolic enzyme is the result of the equilibrium actions between KATs and KDACs 55,56 ( Figure 2 ). Integrating nutrient information and energy signals into a reversible reaction process shows that metabolism may be coordinated by acetylation: when nutrients are plentiful, acetylation may prevent overheating; conversely, when energy levels are low, deacetylation may increase metabolism.
Metabolites homeostasis
Synthetic
Role of acetylation in the coordination of nutrient adaptation The nature of nutrient adaptation involves coordination of the metabolic pathways. Different pathways are activated under different environmental conditions and in the presence of nutrient concentrations. The mechanisms underlying nutrient adaptation in prokaryotic cells have been addressed by microbiologists. Carbon CR (CCR) is a classic mechanism by which bacteria adapt to different nutrient levels. 57 The basic principle underlying CCR is that the most energy-efficient cognate substrate is the most preferred carbon source. This is usually achieved through the inhibition of enzymes involved in the catabolism of other sources of carbon. 58 The molecular machinery of CCR is enforced at different levels, including the transcriptional, post-transcriptional, translational and biochemical levels. 59 However, it seems that each group of bacteria has developed its own means of achieving CCR, and each means of coordination involves different mechanisms. The issue of whether any universal mechanism governs CCR in all bacteria is open to question. Acetylation could be the answer. We tested this hypothesis in Salmonella enterrica. When glucose is plentiful, the universally higher acetylation of the TCA pathway and glyoxylate bypass enzymes facilitates glucose metabolism by activating isocitrate dehydrogenase (IDH), thus activating the TCA cycle and inhibiting glyoxylate bypass enzymes and so inhibiting glyoxylate bypass. Conversely, when citrate is the only carbon source, synchronized lower acetylation of IDH in the TCA pathway and glyoxylate bypass enzymes activates glyoxylate bypass and slows down the TCA pathway. 38 Although eukaryotic cells and bacteria have different metabolic features, they prefer the same nutrients, particularly glucose. The issue of whether eukaryotic cells adapt to the use of different nutrients using the same mechanisms as bacteria is currently unresolved. One way to answer this question is to determine whether there are any bacteria-like organelles in eukaryotic cells and whether these organelles are associated with metabolism. Mitochondria, the powerhouses of all eukaryotic cells, may also be their nutrient-adaptation centers. 60 Genomic sequencing analysis indicates that mitochondria originated from a eubacteria. 61 The top three nutrients of eukaryotic cells, carbohydrates, fatty acids and amino acids, are metabolized through glycolysis, fatty-acid oxidation and the urea cycle, respectively. Strikingly, at least one step of each of these metabolic pathways is carried out inside the mitochondria. Most glycolysis enzymes are located in the cytoplasm. However, pyruvate dehydrogenase complex, which is both the final enzyme and one of the controlling enzymes of glycolysis, is localized inside the mitochondria. 62 Similarly, two out of the five enzymes in the urea cycle, which include the ratelimiting enzyme, carbamoyl phosphate synthetase I and ornithine transcarbamoylase (OTC), are localized inside the mitochondria. These facts, and the fact that most of the enzymes involved in fatty-acid oxidation are located in the mitochondria, indicate that the mitochondria may be a coordination center in eukaryotic cells, allowing them to adapt to different nutrient conditions.
We have previously reported that catalytic activity of OTC is regulated by acetylation. 40 Lysine 88 of OTC is acetylated, and this acetylation causes inhibition of OTC catalytic activity through decreased substrate binding and decreased V max of OTC. 40 Sirt3 was found to be responsible for deacetylating acetylated lysine 88 of OTC. 40, 63 OTC acetylation was found to be enhanced by increased glucose concentration and weakened by increased amino-acid concentration, showing that acetylation is involved in coordinated amino-acid adaptation. 40 Consistent with our findings, carbamoyl phosphate synthetase I activity is also regulated by acetylation, although the reported deacetylase was Sirt5 rather than Sirt3. 64 Hirschey et al. 65 reported that mitochondrial fatty-acid oxidative enzyme long-chain acyl-CoA dehydrogenase is hyperacetylated at lysine 42 and inactivated in the absence of Sirt3. In the Sirt3 wild-type mouse, under fasting conditions, when glucose is scarce, long-chain acyl-CoA dehydrogenase is deacetylated and activated, promoting the utilization of fatty acids as energy sources. However, mice lacking Sirt3 exhibit hallmarks of fatty-acid oxidation disorders during fasting. 65 We also found that another mitochondrial fatty acid, oxidative enzyme enoyl CoA hydrotase/3-hydroxylacyl-CoA dehydrogenase, is activated by glucose-stimulated acetylation. 36 These observations suggest that acetylation may also have a role in coordination of the adaptation between glucose and fatty acids.
Although the manner in which pyruvate dehydrogenase complex is regulated by acetylation remains to be reported, accumulating amounts of evidence support the conclusion that mitochondria serve as a nutrient-adaptation center. Acetylation coordination allows eukaryotic cells to use different nutrients in a hierarchical manner to best suit their physiological needs. Even though mitochondrial acetyltransferases remain to be identified, Sirt3, the mitochondrial yeast Sir2, and Salmonella CobB analog protein, showed appreciable deacetylase activity and may have central roles in nutrient adaptation in mitochondria (Figure 3 ). 66 Role of acetylation in the coordination of metabolite homeostasis Although 2-hydroxylglutarate and some TCA cycle intermediates, such as succinate and fumarate, are known oncometabolites, the manner in which acetylation maintains their homeostasis remains to be clarified. Some recent studies have explored the mechanism by which acetylation maintains metabolite homeostasis. Glucose is the most important nutrient and metabolite in most organisms. Elevated glucose-uptake rates and high glycolysis rate are key features of cancer cells. 3 Glucose homeostasis is determined by glucose uptake, which involves glucose transporters, and glucose utilization, which involves glycolysis and glycogen synthesis pathways. All the enzymes in these pathways are acetylated. 
Protein lysine acetylation guards metabolic homeostasis W Xu et al
The stability of phosphoenolpyruvate carboxykinase 1 (PEPCK1), which is both the first committed and rate-limiting gluconeogenesis enzyme, is regulated by acetylation. Glucose was found to promote the acetylation of PEPCK1. Although acetylation did not alter the catalytic activity of PEPCK1, it promotes the proteosomal degradation of PEPCK1 by recruiting E3 ubiquitin ligase UBR5. 42 In another study, we found GP activity to be negatively regulated by acetylation. Glucose was found to enhance GP acetylation and promote GP dephosphorylation, inactivating GP. 41 One very important feature of these regulations is that glucose serves as an upstream signal. It is therefore reasonable to speculate that acetylation may regulate glucose homeostasis, even without knowing the underlying mechanisms by which acetylation regulates glycolysis and glycogen synthesis (Figure 4) . The homeostasis of metabolites other than glucose may also be coordinated by acetylation.
Role of acetylation in cancer metabolism
Acetylation and the Warburg effect. Mounting evidence has suggested that deregulated acetylation may contribute to the Warburg effect. Glucose uptake and glycolysis events are closely linked to acetylation. Tumor cells express the embryonic M2 isoform of pyruvate kinase (PKM2), which may contribute to the shift in metabolism from oxidative phosphorylation to aerobic glycolysis and tumorigenesis. Acetylation may be involved in this switch. Glucose-stimulated lysine 305 acetylation decreases PKM2 enzyme activity. Ectopic expression of the acetylation mimetic K305Q mutant causes glycolytic intermediates to accumulate, promoting cell proliferation and tumor growth. 67 Accumulation of glycolytic intermediates may activate the Warburg effect. 68, 69 In yeast, NuA4-acetyltransferase-mediated acetylation of Sip2p decreased phosphorylation of the Akt/S6K ortholog Sch9p and linked acetylation to glucose uptake and utilization control. 70 Mammalian Akt was found to promote glucose transporter activity and stimulate glycolysis through activation of several glycolytic enzymes, including hexokinase and phosphofructokinase. 71 If a similar mechanism is adapted in human cells, acetylation may contribute to the Warburg effect by reprogramming glycolysis.
Altered mitochondrial functions and reprogramming of the TCA cycle are also key features of the Warburg effect. Many metabolic enzymes reside in the mitochondria. Reversible acetylation of mitochondrial proteins on lysine residues is a key mechanism by which mitochondria adjust to environmental changes. Acetylome surveys and cell biological assays have demonstrated that mitochondrial metabolic enzymes are heavily acetylated, indicating that mitochondrial metabolism is tightly regulated by acetylation. 33, 36, 37, 45 Among known NAD þ -dependent deacetylases, Sirt3, Sirt4 and Sirt5 are localized to the mitochondria. Of these, Sirt3 has shown the strongest deacetylase activity. The importance of acetylation to mitochondrial metabolic enzymes is highlighted by recent studies of Sirt3-knockout mice. Sirt3 knockout suppresses a number of mitochondrial metabolic enzymes, such as OTC, longchain acyl-CoA dehydrogenase and IDH 2. 40, 43, 65 It is reasonable to speculate that changes in acetylation can reprogram mitochondrial metabolism. This notion is substantiated by a recent quantitative acetylome study that showed Sirt3 to be a prominent regulator in CR adaptation, that Sirt3 coordinates many enzymes in many different metabolic pathways and that mitochondrial maintenance involves Sirt3-mediated deacetylation. 72 The Warburg effect indicates reprogramming of cellular and organismal metabolic homeostasis, and existing evidence indicates a close connection between acetylation and the Warburg effect. 73 Role of acetylation in tumor-associated metabolic genes Mutations in many metabolic enzymes can cause the Warburg effect. Germline fumarate hydratase and succinate dehydrogenase mutations have been observed in patients affected by hereditary leiomyomatosis renal cell cancer, cutaneous leiomyomas, uterine leiomyomas, hereditary paragangliomas and phaeochromocytomas. [74] [75] [76] [77] [78] [79] Fumarate hydratase and succinate dehydrogenase mutations exert their tumorigenic effects by blocking reactions in the TCA cycle and by activating glycolysis via fumarate-and succinate-accumulation-induced hypoxia-inducible factor activation.
78,80-82 NADP þ -dependent IDH mutations have recently been shown to be mutated in secondary glioma, leukemia and some other types of cancers. [83] [84] [85] IDH mutations alter cell metabolism by lowering the TCA product a-ketoglutarate and by producing the oncometabolite 2-hydroxylglutarate. Both these outcomes may inhibit proline hydroxylases and other a-ketoglutarate-dependent dioxygenases, therefore activating glycolysis. 11, 12, 86, 87 There are also a number of enzymes that may be involved in tumorigenesis. For example, overexpression of phosphoglycerate mutase has been shown to transform cells through an unknown mechanism. 88 Elevated expression of enolase, fatty-acid synthetase, transketolase like 1 and phosphoglucose isomerase had been observed in cancers. [89] [90] [91] On the other hand, decreased expression of aconitase had been observed cancer. 92 All these metabolic enzymes are heavily acetylated at multiple lysine sites. However, the mechanisms by which acetylation regulates these enzymes remain undetermined. It is tempting to connect acetylation to the catalytic activities of these enzymes, and so establish a relationship between acetylation and the tumorigenic effects of these enzymes.
Sirtuin inhibition and anticancer treatment Trichostatin, a hydroxamate compound that inhibits KDACs, was found to inhibit cancer. 93 Ever since this discovery was made, inhibitors of KDACs have drawn attention as a new class of anticancer drugs. Suberoyl anilide hydroxamic acid, an analog of trichostatin, became the first Food and Drug Administrationapproved clinical KDAC-inhibitor-based anticancer drug. Since then, increasing numbers of KDAC inhibitors have been approved by the Food and Drug Administration for cancer treatment and many are in the pipeline for approval. 94 In contrast, although the potential of KDAC inhibitors as anticancer reagents has been the subject of many rigorous studies, the mechanism underlying the action of these inhibitors has not yet been completely elucidated. The clinical activity of these inhibitors was controversially thought to be mainly involved in the induction of histone acetylation and to alter the expression of cancer-related genes. 95 KDAC inhibition can prevent and slow cancer development by altering cancer metabolism. This is indicated by the identification of a class of tumor-suppressive sirtuin inhibitors. It is now known that inhibition of sirtuins may change the acetylation states of metabolic enzymes and so alter metabolism. Salermide is a reverse amide with strong in vitro inhibitory effects on Sirt1 and Sirt2. It promotes tumor-specific cell death in human cancer cell lines. 96 Sirtinol, another NAD þ -dependent deacetylase inhibitor, induced senescence-like growth arrest in human breast cancer MCF-7 cells and lung cancer H1299 cells. 97 Cambinol, a sirtinol analog, inhibits human Sirts and can induce apoptosis. 98 Tenovin-1, which was found during an anticancer screening study, inhibits Sirts and decreases tumor growth in vivo even when used alone. 99 The existence of NAD þ -dependent deacetylase-inhibitor anticancer reagents may indicate that these inhibitors exert anticancer effects by resetting the metabolism of cancer cells to that of normal cells.
OPEN QUESTIONS AND FUTURE DIRECTIONS
Emerging evidence for the roles of acetylation in the regulation of metabolic enzymes, metabolic pathway coordination and the maintenance of metabolic homeostasis brings new thinking of how to contain cancer by mediating acetylation. It also raises a series of questions. First, the molecular mechanisms by which acetylation regulates individual metabolic enzymes must be described in detail before any acetylation-coordinated metabolic network can be established. The manner in which the metabolic enzymes involved in the Warburg effect and those whose activities are altered in tumors are regulated by acetylation will be of particular importance.
The establishment of an acetylation-coordinated metabolic network will require further studies on the regulators of protein acetylation. KATs and KDACs are strikingly conserved across species, from prokaryotes to humans. Mutations in both KATs and KDACs are associated with diseases such as cancer. Although more than 6000 acetylated proteins have been identified so far, the number of KATs and KDACs is surprisingly small. 100 Each group has o30 members. 101 The discrepancy between the number of acetylated proteins and the number of acetylation regulators suggests a highly interconnected acetylation regulation network. Considering that acetylation has a versatile role in the regulation of cell physiology, the coordinating role of acetylation is critically important, but not to be limited to metabolism to cellular functions. This is evident by the fact that class I deacetylases mainly act on histones and nuclear proteins to regulate transcription, and sirtuins can localize in mitochondria to regulate metabolism, as well as localize in the nucleus to regulate transcription. Therefore, acetylation is likely a coordinator of both cell signaling and cell metabolism, because of its versatile roles in transcriptional and metabolic regulation ( Figure 5 ). However, no matter how cell signaling is altered by acetylation-caused transcription changes or cell metabolism is changed by the different acetylation status of metabolic enzymes, the results of disturbing this signaling network, based on current understanding, are usually reflected in altered metabolite homeostasis. With the roles of different metabolites in cell signaling control being elucidated, and with how metabolic pathway coordination is disturbed in complex human diseases such as in cancer is understood, understanding how alterations in acetylation cause metabolic changes is taking the center of the study of disease control. A greater understanding of the role of acetylation in metabolic coordination and the molecular mechanisms by which they act may provides new avenues to the control of cancer and prevention of human tumors. 
